Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation

Chinese University of Hong Kong

PubMed
Indexed incrossrefdoajpubmed

Abstract

TGF-β1 has been long considered as a key mediator in renal fibrosis and induces renal scarring largely by activating its downstream Smad signaling pathway. Interestingly, while mice overexpressing active TGF-β1 develop progressive renal injury, latent TGF-β1 plays a protective role in renal fibrosis and inflammation. Under disease conditions, Smad2 and Smad3 are highly activated, while Smad7 is degraded through the ubiquitin proteasome degradation mechanism. In addition to TGF-β1, many pathogenic mediators such as angiotensin II and advanced glycation end products can also activate the Smad pathway via both TGF-β-dependent and independent mechanisms. Smads interact with other signaling pathways, such as the…

Citation impact

636
total citations
FWCI
14.23
Percentile
100%
References
82
Citations per year

Authors

1

Topics & keywords

Keywords
  • SMAD
  • Inflammation
  • Fibrosis
  • Mediator
  • Kidney
  • Signal transduction
  • Cancer research
  • Angiotensin II
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding